非小细胞肺癌术后随访中国胸外科专家共识(2025版)  

Chinese expert consensus on postoperative follow-up for non-small cell lung cancer(version 2025)

作　　者：刘伦旭[1] 高树庚[2] 何建行[3] 胡坚[4] 葛棣 李鹤成[6] 康明强[7] 谭锋维[2] 杨帆[8] 蒲强[1] 蔡开灿[9] 中国医师协会胸外科医师分会 中国医药教育协会胸外科专业委员会 LIU Lunxu;GAO Shugeng;HE Jianxing;HU Jian;GE Di;LI Hecheng;KANG Mingqiang;TAN Fengwei;YANG Fan;PU Qiang;CAI Kaican;Chinese Medical Doctor Association ThoracicSurgeons Branch;Thoracic Surgery Society of China Medical Education Association(Department of Thoracic Surgery,West China Hospital,Sichuan University,Chengdu,610041,P.R.China;Department of Thoracic Surgery,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences,Beijing,100021,P.R.China;Department of Thoracic Surgery,The First Affiliated Hospital of Guangzhou Medical University,Guangzhou,510120,P.R.China;Department of General Thoracic Surgery,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,310003,P.R.China;Department of Thoracic Surgery,Zhongshan Hospital,Fudan University,Shanghai,200032,P.R.China;Department of Thoracic Surgery,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,200025,P.R.China;Department of Thoracic Surgery,Union Hospital,Fujian Medical University,Fuzhou,350001,P.R.China;Department of Thoracic Surgery,Peking University People's Hospital,Beijing,100044,P.R.China;Department of Thoracic Surgery,Nanfang Hospital,Southern Medical University,Guangzhou,510515,P.R.China;不详)

机构地区：[1]四川大学华西医院胸外科,成都610041 [2]中国医学科学院肿瘤医院胸外科,北京100021 [3]广州医科大学附属第一医院胸外科,广州510120 [4]浙江大学医学院附属第一医院普胸外科,杭州310003 [5]复旦大学附属中山医院胸外科,上海200032 [6]上海交通大学医学院附属瑞金医院胸外科,上海200025 [7]福建医科大学附属协和医院胸外科,福州350001 [8]北京大学人民医院胸外科,北京100044 [9]南方医科大学南方医院胸外科,广州510515 [10]不详

出　　处：《中国胸心血管外科临床杂志》2025年第3期281-290,共10页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

摘　　要：外科手术是非小细胞肺癌(non-small cell lung cancer,NSCLC)治疗的重要手段之一,术后定期随访是早期发现和及时治疗肿瘤复发、转移病灶或第二原发肿瘤的关键措施。科学合理的随访策略不仅可以延长患者生存期,还能显著提升生活质量,从而改善整体预后。本共识的制定旨在前一版随访共识基础上,根据目前最新临床研究进展,进一步根据不同治疗模式完善我国NSCLC早期患者的术后随访方案,为从事NSCLC术后随访管理的临床医师提供科学、可操作的参考依据。本共识希望通过优化随访策略,推动我国肺癌诊疗的规范化和标准化水平,助力更多患者获得更优质的治疗和长期管理。同时,本共识的发布也期望为国内外相关研究和临床实践提供借鉴,推动NSCLC术后管理领域的持续发展和创新。Surgical treatment is one of the key approaches for non-small cell lung cancer(NSCLC).Regular postoperative follow-up is crucial for early detection and timely management of tumor recurrence,metastasis,or second primary tumors.A scientifically sound and reasonable follow-up strategy not only extends patient survival but also significantly improves quality of life,thereby enhancing overall prognosis.This consensus aims to build upon the previous version by incorporating the latest clinical research advancements and refining postoperative follow-up protocols for early-stage NSCLC patients based on different treatment modalities.It provides a scientific and practical reference for clinicians involved in the postoperative follow-up management of NSCLC.By optimizing follow-up strategies,this consensus seeks to promote the standardization and normalization of lung cancer diagnosis and treatment in China,helping more patients receive high-quality care and long-term management.Additionally,the release of this consensus is expected to provide insights for related research and clinical practice both domestically and internationally,driving continuous development and innovation in the field of postoperative management for NSCLC.

关 键 词：非小细胞肺癌 术后随访 胸外科 专家共识 

分 类 号：R73[医药卫生—肿瘤]